Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Exploration of Neural Bases in Social Cognition (IRM-COG)

4. februar 2015 opdateret af: University Hospital, Caen

An impairment in social cognition in schizophrenia could account for the severe professional and social difficulties among patients. Social cognition is the way the social world is understood, perceived and interpreted. It includes all the process than enable oneself to interact with another person, namely emotion perception and processing, theory of mind (ToM), social perception, social knowledge and attributional style. Since these process are interconnected, social cognition should be investigated through ecological tasks which activate all of them together. Developing a social cognition ecological task, then testing the reproducibility of the functional magnetic resonance imagery (fMRI) BOLD signal is the main objective of this study. The secondary objective is to seek a functional deficit among the neural network of social cognition in patients with schizophrenia compared with healthy subjects.

Forty healthy subjects, aged from 18 to 60 years old, who have given a written consent, will be included. The social cognition paradigm will be developed and the fMRI activations will be compared to those of a visual cartoon based task, known to turn on the neural network of ToM. BOLD signal variations at a high statistical correction ratio (p<0.05) will be explored and compared to the signal of a second fMRI, made on the same 20 healthy subjects one month later, to test reproducibility (% of identical activated voxels during the 2 fMRI, p<0.05).

Twenty matched patients with schizophrenia (DSM-IV-R), aged from 18 to 60 will be included to test the secondary objective. We make the hypothesis of a fMRI functional alteration in the cerebral network involved in social cognition, especially in the medial prefrontal cortex, among patients compared with healthy subjects.

Studieoversigt

Detaljeret beskrivelse

Social cognition neural basis. Impairment of the "social brain" in schizophrenia

Undersøgelsestype

Interventionel

Tilmelding (Forventet)

60

Fase

  • Ikke anvendelig

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiesteder

    • Normandy
      • Caen, Normandy, Frankrig, 14000
        • Rekruttering
        • Centre Hospitalier Universitaire
        • Kontakt:
          • Perrine Brazo, MD-PhD
          • Telefonnummer: 0033231065018
        • Kontakt:
        • Ledende efterforsker:
          • Perrine BRAZO, MD-PhD
        • Ledende efterforsker:
          • Sonia DOLLFUS, MD-PhD
        • Ledende efterforsker:
          • Pascal DELAMILLIEURE, MD-PhD
        • Ledende efterforsker:
          • Vincent MARZLOFF, MD

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

18 år til 60 år (Voksen)

Tager imod sunde frivillige

Ingen

Køn, der er berettiget til at studere

Alle

Beskrivelse

Inclusion Criteria:

  • Subjects aged from 18 to 60 years old
  • who have signed a consent and, if there is one, whose legal representant has signed a consent

    1)For healthy subjects:

  • without any psychiatric affection (Mini International Neuropsychiatric Interview)

    2)For patients

  • meeting the DSM-IV-R criteria for schizophrenia or schizoaffective disorder

Exclusion Criteria:

  • pregnant woman
  • neurological affection
  • medical objection to Magnetic Resonance Imagery (MRI)

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Sundhedstjenesteforskning
  • Tildeling: Ikke-randomiseret
  • Interventionel model: Parallel tildeling
  • Maskning: Ingen (Åben etiket)

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Andet: Patients with schizophrenia

Twenty patients suffering from schizophrenia (DSM-IV-R), with medication and medical care. No recent relapse of the psychotic disease, nor change in medications.

No neurological comorbidity.

After anatomic scans, each subject will go through the fMRI social cognition task.

fMRI social cognition task : each subject will go through 3 runs of a fMRI paradigm, first one verbal then two visual runs, which are meant to activate the theory of mind network.
Andre navne:
  • Philips 3 Tesla fMRI
Andet: Healthy subjects

Twenty healthy subjects (no mental or neurological disease)

After anatomic scans, each subject will go through the fMRI social cognition task.

fMRI social cognition task : each subject will go through 3 runs of a fMRI paradigm, first one verbal then two visual runs, which are meant to activate the theory of mind network.
Andre navne:
  • Philips 3 Tesla fMRI

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Developing a social cognition ecological task, then testing the reproducibility of the functional magnetic resonance imagery (fMRI) BOLD signal
Tidsramme: Day 1 for individual analysis. Up to 24 months for group analysis.
The social cognition paradigm will be developed and the fMRI activations will be compared to those of a visual cartoon based task, known to turn on the neural network of ToM. BOLD signal variations at a high statistical correction ratio (p<0.05) will be explored and compared to the signal of a second fMRI, made on the same 20 healthy subjects one month later, to test reproducibility (% of identical activated voxels during the 2 fMRI, p<0.05)
Day 1 for individual analysis. Up to 24 months for group analysis.

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Identifying a functional deficit among the neural network of social cognition in patients with schizophrenia compared with healthy subjects.
Tidsramme: Day 1 for individual analysis. Up to 24 months for group analysis.
Using the previous social cognition ecological task, BOLD signal variations at a high statistical correction ratio (p<0.05) of 20 patients with schizophrenia will be compared to those of 20 matched healthy subjects.
Day 1 for individual analysis. Up to 24 months for group analysis.

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Efterforskere

  • Ledende efterforsker: Perrine BRAZO, MD-PhD, University of Caen, UMR 6301 ISTCT ISTS group; CNRS UMR 6301 ISTCT GIP Cyceron; CEA UMR 6301 ISTCT; CHU de Caen, Department of psychiatry, Centre Esquirol

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart

1. september 2013

Primær færdiggørelse (Forventet)

1. september 2015

Studieafslutning (Forventet)

1. september 2015

Datoer for studieregistrering

Først indsendt

12. september 2013

Først indsendt, der opfyldte QC-kriterier

8. april 2014

Først opslået (Skøn)

10. april 2014

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Skøn)

5. februar 2015

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

4. februar 2015

Sidst verificeret

1. februar 2015

Mere information

Begreber relateret til denne undersøgelse

Andre undersøgelses-id-numre

  • RCB 2013-A00064-41

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Abonner